PAK1 and glioblastoma: The acetylation modification and kinase activity of PAK1 were considered to be an instrumental role in hypoxia-induced autophagy initiation and maintaining GBM growth, and PAK1 might represent potential therapeutic targets for GBM treatment (Feng et al., 2020).